Article ID Journal Published Year Pages File Type
3998989 Surgical Oncology Clinics of North America 2008 16 Pages PDF
Abstract

Although prospective, randomized clinical trials never have been conducted, retrospective and comparative studies strongly indicate that hepatic resection is the only available treatment that allows long-term survival in colorectal carcinoma that has metastasized to the liver. Unfortunately, curative resection can be performed in less than 25% of the patients. Ten years ago, hepatic resection was contraindicated in case of multiple or bilobar nodules. Currently, the trend is to be more aggressive and to increase the indications for surgical resection with the development of new strategies using a multidisciplinary approach.

Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, ,